Genes such as KLK3, encoding prostate-specific antigen (PSA), are direct transcriptional targets of the AR, and their expression is often used as a surrogate for AR activity in PCa research and clinical monitoring[132]. This evidence concerns the gene KLK3 and posterior cortical atrophy.